-
1دورية أكاديمية
المؤلفون: Wolters, Sharon, de Jong, Lisa A., Jansen, Christel, Jansman, Frank G.A., Postma, Maarten J.
المصدر: Wolters , S , de Jong , L A , Jansen , C , Jansman , F G A & Postma , M J 2024 , ' Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies : can alignment be improved? ' , Expert Review of Pharmacoeconomics and Outcomes Research , vol. 24 , no. 2 , pp. 251-265 . https://doi.org/10.1080/14737167.2023.2263166Test
مصطلحات موضوعية: Evidence generation, health technology assessment, oncology drugs, reimbursement, relative effectiveness assessments
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1080/14737167.2023.2263166Test
https://hdl.handle.net/11370/3d403b07-e0ed-400b-831b-dcb763f0a4d4Test
https://research.rug.nl/en/publications/3d403b07-e0ed-400b-831b-dcb763f0a4d4Test
https://pure.rug.nl/ws/files/925136514/Differences_in_evidentiary_requirements_for_oncology_drug_effectiveness_assessments_among_six_European_health_technology_assessment_bodies_can_align.pdfTest
http://www.scopus.com/inward/record.url?scp=85173929693&partnerID=8YFLogxKTest -
2دورية أكاديمية
المساهمون: European Federation of Pharmaceutical Industries and Associations
المصدر: Expert Review of Pharmacoeconomics & Outcomes Research ; volume 24, issue 2, page 251-265 ; ISSN 1473-7167 1744-8379
-
3دورية أكاديمية
المؤلفون: Wolters, Sharon1,2 (AUTHOR) sharon@ascacademics.com, Carpay, Johannes A.3 (AUTHOR), Pronk, Marja H.4 (AUTHOR), Zuurbier, Karin W.M.5 (AUTHOR), Driessen, Maurice T.6 (AUTHOR), Lyras, Leonidas6 (AUTHOR), Postma, Maarten J.1,7 (AUTHOR)
المصدر: BMC Neurology. 6/24/2024, Vol. 24 Issue 1, p1-12. 12p.
مصطلحات موضوعية: *CALCITONIN gene-related peptide, *MIGRAINE, *COST effectiveness, *PATIENT care
مصطلحات جغرافية: NETHERLANDS
-
4دورية أكاديمية
المصدر: Expert Review of Pharmacoeconomics & Outcomes Research; Feb2024, Vol. 24 Issue 2, p251-265, 15p
-
5دورية أكاديمية
المؤلفون: Wolters, Sharon, Jansman, Frank G.A., Postma, Maarten J.
المصدر: Wolters , S , Jansman , F G A & Postma , M J 2022 , ' Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs—Can Alignment Be Enhanced? ' , Value in Health , vol. 25 , no. 12 , pp. 1958-1966 . https://doi.org/10.1016/j.jval.2022.05.006Test
مصطلحات موضوعية: evidence generation, health technology assessment, oncology drugs, review and reimbursement
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.jval.2022.05.006Test
https://hdl.handle.net/11370/ec2506f6-9d82-41ae-bd57-bd64fcaf154aTest
https://research.rug.nl/en/publications/ec2506f6-9d82-41ae-bd57-bd64fcaf154aTest
https://pure.rug.nl/ws/files/621548870/PIIS1098301522019878.pdfTest
http://www.scopus.com/inward/record.url?scp=85132877175&partnerID=8YFLogxKTest -
6دورية أكاديمية
المصدر: Clinical Pharmacokinetics ; volume 58, issue 5, page 565-592 ; ISSN 0312-5963 1179-1926
مصطلحات موضوعية: Pharmacology (medical), Pharmacology
-
7دورية أكاديمية
المصدر: Clinical Pharmacokinetics; May2019, Vol. 58 Issue 5, p565-592, 28p
مصطلحات موضوعية: ALISKIREN, PLATELET aggregation inhibitors, HEPATITIS C, CARDIOVASCULAR agents, CALCIUM antagonists, ANGIOTENSIN-receptor blockers
الشركة/الكيان: EUROPEAN Medicines Agency, UNITED States. Food & Drug Administration
-
8دورية أكاديمية
المؤلفون: Lien, Yeong-Hau H., Maricic, Michael J., Scott, Katherine, Ditmanson, Leonard F., Wolters, Sharon
المصدر: JCR: Journal of Clinical Rheumatology ; volume 5, issue 6, page 373 ; ISSN 1076-1608
الإتاحة: https://doi.org/10.1097/00124743-199912000-00018Test
http://journals.lww.com/00124743-199912000-00018Test -
9دورية
المؤلفون: Lien, Yeong-Hau H., Maricic, Michael J., Scott, Katherine, Ditmanson, Leonard F., Wolters, Sharon
المصدر: Journal of Clinical Rheumatology; December 1999, Vol. 5 Issue: 6 p373-373, 1p